Evidence map›Paper›PMID 41476514›Full record

ReviewACS omega2025

Alternative H

Stavros-Alexandros Theofanidis, Amvrosios G Georgiadis, Christianus J W Hop, Xiaobin Yu, Vasileia-Loukia Yfanti, Guillaume Fayet, Claire Villemur, Hank Vleeming, Evangelos Delikonstantis, Richard H Heyn

Abstract readReview
In one paragraph

Review in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Engineered Framework Photocatalysts for Green HSmall (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Stavros-Alexandros TheofanidisAristEng S.à r.l., 20, Avenue Pasteur, Luxembourg City L-2310, Luxembourg.ORCID https://orcid.org/0000-0002-3859-7135
Amvrosios G GeorgiadisAristEng S.à r.l., 20, Avenue Pasteur, Luxembourg City L-2310, Luxembourg.
Christianus J W HopProcess Design Center BV, Paardeweide 7, Breda NL-4824EH, The Netherlands.
Xiaobin YuProcess Design Center BV, Paardeweide 7, Breda NL-4824EH, The Netherlands.
Vasileia-Loukia YfantiAristEng S.à r.l., 20, Avenue Pasteur, Luxembourg City L-2310, Luxembourg.
Guillaume FayetIneris, Parc Technologique ALATA, BP 2, Verneuil-en-Halatte 60550, France.
Claire VillemurIneris, Parc Technologique ALATA, BP 2, Verneuil-en-Halatte 60550, France.
Hank VleemingProcess Design Center BV, Paardeweide 7, Breda NL-4824EH, The Netherlands.ORCID https://orcid.org/0000-0001-9526-9165
Evangelos DelikonstantisAristEng S.à r.l., 20, Avenue Pasteur, Luxembourg City L-2310, Luxembourg.ORCID https://orcid.org/0000-0002-4727-3327
Richard H HeynSINTEF Industry, P.O. Box 124 Blindern, Oslo 0314, Norway.ORCID https://orcid.org/0000-0001-5670-4320

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hydrogen peroxide is currently made on a large scale via the auto-oxidation (AO) process, an indirect process via the hydrogenation of anthraquinone over a Pd catalyst, followed by reaction with O

Identifiers

PMID41476514
PMCPMC12750225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.